No takes yet. Share an insight, caveat, or question.
Randomized trial uncovers CR1's role in promoting immunosuppressive conditions in hepatocellular carcinoma, suggesting new therapeutic strategies.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: